This document contains a series of desk reviews for the eight ENGAGE-TB priority countries supported by the Global Fund (DRC, Kenya, Indonesia, Mozambique, Myanmar, Nigeria, Pakistan and Tanzania). The document provides a situation assessment and gap analysis about the state of community based TB ac...tivities in these countries. The focus on these eight countries was justified by the high prevalence of TB and the very high number of missed/unreported cases.
more
Le suicide est évitable. Pourtant, toutes les 40 secondes, une personne se suicide quelque part dans le monde et bien plus tentent de mettre fin à leurs jours. Aucune région ni aucune tranche d’âge n’est épargnée. Il touche toutefois particulièrement les jeunes de 15 à 29 ans, chez qui i...l constitue la deuxième cause de mortalité à l’échelle mondiale
more
The seven essential features of practice for scaling up are described with great clarity. They are practical and universal, and encourage local innovation. They include policy, funding and local management structure, as well as working with all possible partners and developing local context adaptati...ons. The case studies give ideas and inspiration to develop new programmes and find ways around obstacles in existing programmes, especially through involving those with most at stake including users and their families and local community leaders
more
BMJ 2020;368:m800 doi: 10.1136/bmj.m800 (Published 5 March 2020)
Access to controlled medicines. 3rd edition
Palm Oil and Children in Indonesia : Exploring the Sector's Impact on Children's Rights
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac...hed a tipping point where large and prominent drugmakers have retreated from the antibiotics field and smaller innovative biotech companies have gone bankrupt due to the poor financial rewards on offer.
more
DOI 10.15252/emmm.201404792 |Published online 30.12.2014
EMBO Molecular Medicine(2014)emmm.201404792
The Lancet. Published Online December 22, 2016 http://dx.doi.org/10.1016/S0140-6736(16)32621-6. Open Access
Weekly Epidemiological Record (WER), 17 September 2021, Vol. 96, No. 37 (pp. 445-460)
Clinical Medicine
JCI Insight. 2017;2(7):e91963.
Eur Respir J 2014; 43: 24–35 | DOI: 10.1183/09031936.00113413
(Health Systems in Transition, Vol. 4, No. 3, 2014)